X 2 Apologies .. posted on correct forum Post



Extract Leading Driver In The Prostate Cancer Therapeutics Market 2025: Surge In Aging Population And Increased Life Expectancy - World News Report - EIN Presswire (einnews.com)

Leading Driver In The Prostate Cancer Therapeutics Market 2025: Surge In Aging Population And Increased Life Expectancy

The Business Research Company

The Business Research Company's Prostate Cancer Therapeutics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034

What Is The Growth Trajectory Of The Prostate Cancer Therapeutics Market?
The prostate cancer therapeutics market has seen a noteworthy expansion recently. The valuation of this market is expected to grow from $11.92 billion in 2024 to $13.00 billion in 2025, registering a Compound Annual Growth Rate CAGR of 9.0%. The driving force behind this growth can be attributed to the global rise in prostate cancer incidences, awareness about early cancer screening and diagnostic programs, a growing elderly male population, and an increasing demand for personalized and targeted therapies.

How Fast Will The Prostate Cancer Therapeutics Market Grow In The Coming Years?
Foresights for the future are even more encouraging, with the market size expected to reach $18.16 billion in 2029, posting a CAGR of 8.7%. Emerging economies' increased spending in healthcare, burgeoning investments in oncology drugs, greater accessibility of advanced imaging and diagnostic tools, and the rising preference for minimally invasive and non-surgical treatments are factors contributing to this favorable future outlook. Advancements in targeted cancer therapies, precision cancer medicine integration, technological advancements in diagnostic imaging tools, developments in radioligand-based treatments, and progress in immunotherapy for prostate cancer are a few trends to lookout for in the forecast period.

Who Are The Key Players Operating In The Prostate Cancer Therapeutics Market?
Noteworthy players in the prostate cancer therapeutics market are et al., Telix Pharmaceuticals,